Skip to main content
Equibles
MYGN logo

MYGN · Myriad Genetics Inc · Analyst Estimates

Track MYGN — free

Use MYGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MYGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.63 +0.00 (+0.00%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$634.16M
Shares
95.65M
Volume · Oct 29 414.26K Avg daily vol (3M) 2.63M

Analyst Estimates

Compare analyst forecasts for Myriad Genetics Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-28 21:41 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.89
-0.74
-0.58
9
-0.74
-0.75
-0.76
0.048
0
0
1
0
Revenue
USD
Publication date not stated
772.68M
777.92M
784.00M
9
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.76
-0.59
-0.46
9
-0.59
-0.57
-0.57
0.15
1
0
0
0
Revenue
USD
Publication date not stated
805.51M
820.46M
845.10M
9
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.27
-0.20
-0.15
8
-0.20
-0.21
-0.21
0.071
1
8
0
0
Revenue
USD
Publication date not stated
188.60M
191.33M
192.64M
8
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.24
-0.18
-0.09
8
-0.18
-0.19
-0.20
0.12
1
8
0
0
Revenue
USD
Publication date not stated
192.98M
196.11M
200.90M
8
 — — — — — — — —
Key facts CIK 899923 CUSIP 62855J104 13F (30d) 25 filings 25 filers Visit website Investor relations